---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254354349.md"
description: "The A-share CRO concept sector has seen a surge, with Lionco hitting the daily limit, MeHow rising over 10%, and Haoyuan Pharmaceutical, Boji Pharmaceutical, Medicilon, Sun-Novo, and Heyuan Biotechnology also following suit"
datetime: "2025-08-25T02:14:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254354349.md)
  - [en](https://longbridge.com/en/news/254354349.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254354349.md)
---

# 

The A-share CRO concept sector has seen a surge, with Lionco hitting the daily limit, MeHow rising over 10%, and Haoyuan Medicine, Boji Medicine, Medicilon, Sun-Novo, and Heyuan Biology also following suit

### Related Stocks

- [688202.CN](https://longbridge.com/en/quote/688202.CN.md)
- [688621.CN](https://longbridge.com/en/quote/688621.CN.md)
- [603669.CN](https://longbridge.com/en/quote/603669.CN.md)
- [301363.CN](https://longbridge.com/en/quote/301363.CN.md)

## Related News & Research

- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [Premium skincare brand Forest Cabin will study L’Oreal, but not copy it: CEO interview](https://longbridge.com/en/news/286831488.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)